Factor VII-activating protease in patients with acute deep venous thrombosis.

[1]  K. Preissner,et al.  Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome* , 2007, Journal of Biological Chemistry.

[2]  J. Jespersen,et al.  Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis , 2007, Scandinavian journal of clinical and laboratory investigation.

[3]  K. Preissner,et al.  The G534E polymorphism of the gene encoding the factor VII–activating protease is associated with cardiovascular risk due to increased neointima formation , 2006, The Journal of experimental medicine.

[4]  T. Dörner,et al.  Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: Frequency distribution in a healthy German population , 2006, Thrombosis and Haemostasis.

[5]  T. Dörner,et al.  Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism , 2006, Thrombosis and Haemostasis.

[6]  K. Preissner,et al.  A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding. , 2006, The Biochemical journal.

[7]  P. Mannucci,et al.  Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism. , 2006, Blood.

[8]  O. Wagner,et al.  Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism , 2005, Thrombosis and Haemostasis.

[9]  J. Dodt,et al.  The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migration. , 2005, Cellular signalling.

[10]  F. Rosendaal,et al.  The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis. , 2005, Blood.

[11]  T. Dörner,et al.  Marburg I polymorphism of factor VII-activating protease is associated with idiopathic venous thromboembolism. , 2005, Blood.

[12]  R. Colman,et al.  The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation. , 2004, Archives of medical research.

[13]  S. Humphries,et al.  The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. , 2004 .

[14]  K. Preissner,et al.  Factor VII activating protease (FSAP) inhibits growth factor‐mediated cell proliferation and migration of vascular smooth muscle cells. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  S. Kiechl,et al.  Marburg I Polymorphism of Factor VII–Activating Protease: A Prominent Risk Predictor of Carotid Stenosis , 2003, Circulation.

[16]  J. Dodt,et al.  The Hyaluronan-Binding Serine Protease from Human Plasma Cleaves HMW and LMW Kininogen and Releases Bradykinin , 2002, Biological chemistry.

[17]  J. Römisch,et al.  Factor VII Activating Protease (FSAP): A Novel Protease in Hemostasis , 2002, Biological chemistry.

[18]  T. Weimer,et al.  The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP) , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[19]  J. Jespersen,et al.  Internal Quality Control of PCR-based Genotyping Methods in Research Studies and Patient Diagnostics , 2002, Thrombosis and Haemostasis.

[20]  K. Preissner,et al.  Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme. , 2001, European journal of biochemistry.

[21]  A. Feussner,et al.  Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[22]  J. Römisch,et al.  The FVII Activating Protease Cleaves Single-Chain Plasminogen Activators , 2000, Pathophysiology of Haemostasis and Thrombosis.

[23]  J. Römisch,et al.  A protease isolated from human plasma activating factor VII independent of tissue factor. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[24]  K. Valji,et al.  Vascular and Interventional Radiology , 1999 .

[25]  T. Tobe,et al.  Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator. , 1996, Journal of biochemistry.

[26]  J. Jespersen,et al.  Does Low Protein Concentration of Tissue-type Plasminogen Activator Predict a Low Risk of Spontaneous Deep Vein Thrombosis? , 1995, Thrombosis and Haemostasis.

[27]  B. Lämmle.  50. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. , 2006, Hämostaseologie.

[28]  S. Kahn,et al.  The relationship between inflammation and venous thrombosis , 2005, Thrombosis and Haemostasis.